Ruymann F[au] - Search Results

Year	Number of Results
1962	1
1969	1
1970	1
1971	2
1972	1
1974	2
1977	3
1978	3
1979	2
1980	1
1981	1
1982	4
1983	3
1984	2
1985	3
1986	6
1987	3
1988	2
1989	1
1990	4
1991	2
1992	2
1993	2
1994	3
1995	5
1997	6
1998	4
1999	5
2000	3
2001	7
2002	5
2003	8
2004	1
2006	3
2007	2
2008	3
2009	2
2011	1
2015	1
2021	0

1

Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease.

Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. Crist WM, et al. Among authors: ruymann fb. J Clin Oncol. 2001 Jun 15;19(12):3091-102. doi: 10.1200/JCO.2001.19.12.3091. J Clin Oncol. 2001. PMID: 11408506 Clinical Trial.

2

Kappa-chain deficiency.

Bernier GM, Gunderman JR, Ruymann FB. Bernier GM, et al. Among authors: ruymann fb. Blood. 1972 Dec;40(6):795-805. Blood. 1972. PMID: 4117311 Free article. No abstract available.

3

Acquired von Willebrand Syndrome in congenital heart disease: does it promote an increased bleeding risk?

Onimoe G, Grooms L, Perdue K, Ruymann F. Onimoe G, et al. Among authors: ruymann f. Br J Haematol. 2011 Dec;155(5):622-4. doi: 10.1111/j.1365-2141.2011.08732.x. Epub 2011 May 14. Br J Haematol. 2011. PMID: 21569008 Review. No abstract available.

4

Rhabdomyosarcoma in children and adolescents. A review.

Ruymann FB. Ruymann FB. Hematol Oncol Clin North Am. 1987 Dec;1(4):621-54. Hematol Oncol Clin North Am. 1987. PMID: 3323176 Review.

5

The development of VAC chemotherapy in rhabdomyosarcoma: what does one do for an encore?

Ruymann FB. Ruymann FB. Curr Oncol Rep. 2003 Nov;5(6):505-9. doi: 10.1007/s11912-003-0012-z. Curr Oncol Rep. 2003. PMID: 14521810 Review.

6

Therapeutic ERCP in outpatients.

Tham TC, Vandervoort J, Wong RC, Lichtenstein DR, Van Dam J, Ruymann F, Farraye F, Carr-Locke DL. Tham TC, et al. Among authors: ruymann f. Gastrointest Endosc. 1997 Mar;45(3):225-30. doi: 10.1016/s0016-5107(97)70263-3. Gastrointest Endosc. 1997. PMID: 9087827

7

Carcinoid tumors in children and adolescents: risk for second malignancies.

Fernández KS, Aldrink JH, Ranalli M, Ruymann FB, Caniano DA. Fernández KS, et al. Among authors: ruymann fb. J Pediatr Hematol Oncol. 2015 Mar;37(2):150-3. doi: 10.1097/MPH.0000000000000280. J Pediatr Hematol Oncol. 2015. PMID: 25374281

8

Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group experience (1977-1988).

Steuber CP, Culbert SJ, Ravindranath Y, Krischer J, Ragab A, Civin C, Inoue S, Ruymann F, Leventhal B, Wilkinson R, et al. Steuber CP, et al. Among authors: ruymann f. Haematol Blood Transfus. 1990;33:198-209. doi: 10.1007/978-3-642-74643-7_37. Haematol Blood Transfus. 1990. PMID: 2182412 Review. No abstract available.

9

Use of brachytherapy to preserve function in children with soft-tissue sarcomas.

Nag S, Fernandes PS, Martinez-Monge R, Ruymann FB. Nag S, et al. Among authors: ruymann fb. Oncology (Williston Park). 1999 Mar;13(3):361-69; discussion 369-70, 373-4. Oncology (Williston Park). 1999. PMID: 10204155 Free article. Review.

10

Prenatal presentation supports the in utero development of congenital leukemia: a case report.

Bayoumy M, Wynn T, Jamil A, Kahwash S, Klopfenstein K, Ruymann F. Bayoumy M, et al. Among authors: ruymann f. J Pediatr Hematol Oncol. 2003 Feb;25(2):148-52. doi: 10.1097/00043426-200302000-00013. J Pediatr Hematol Oncol. 2003. PMID: 12571468 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results